Age-matched comparison of recombinant and urinary HCG for final follicular maturation

Reproductive BioMedicine Online

Volumn 13, Issue 3, 2006, Pages 315-320

  Uhler, Meike L ^a   Beltsos, Angeline N ^a   Grotjan, H Edward ^b   Lederer, Kevin J ^a   Lifchez, Aaron S ^a  

^a Fertility Centers of Illinois   (United States)

^b EMD SERONO INC   (United States)

Author keywords

Final follicular maturation; Recombinant HCG; Urinary HCG

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; GANIRELIX; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; AGE; ARTICLE; BLASTOCYST; CELL COUNT; CLINICAL PROTOCOL; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; EMBRYO TRANSFER; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OOCYTE MATURATION; ORGAN SIZE; OVARY FOLLICLE MATURATION; OVULATION INDUCTION; PREGNANCY RATE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 33748591362     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61433-2     Document Type: Article

References (19)

1. Abdelmassih V, Oliveira FG, Goncalves SP et al. 2005 A prospective, randomized and blinded comparison between 10,000 IU urinary and 250 microg recombinant human chorionic gonadotropin for oocyte maturation in in vitro fertilization cycles. Journal of Assisted Reproduction and Genetics 22, 149-153.
2. Al-Inany HG, Aboulghar M, Mansour R, Proctor M 2005 Recombinant versus urinary human chorionic gonadotropin for ovulation induction in assisted conception. The Cochran Database of Systemic Reviews, Issue 2. Art. No. CD003719. pub 2. DOI: 10.1002/14651858. CD003719.pub2.
3. Beckers NG, Macklon NS, Eijkemans MJ et al. 2003 Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in-vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. Journal of Clinical Endocrinology and Metabolism 88, 4186-4192.
4. Caglar GS 2005 Recombinant LH in ovarian stimulation. Reproductive BioMedicine Online 10, 774-785.
5. Chang P, Kenley S, Burns T et al. 2001 Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertility and Sterility 76, 67-74.
6. Daya S, Gunby J 2002 Singleton pregnancy resulting from recombinant versus urinary human chorionic gonadotrophin - a meta-analysis. Fertility and Sterility 78 (Suppl. 1), S147-S148 [Abstr. P-94].
7. Driscoll GL, Tyler JP, Hangan JT et al. 2000 A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Human Reproduction 15, 1305-1310.
8. Jansen CAM 2004 Comparison of recombinant hCG to urinary hCG (Letter to the Editor). Fertility and Sterility 17, 480-481.
9. Gemzell C 1965 Induction of ovulation with human gonadotropins. Recent Progress in Hormone Research 21, 179-204.
10. Gomez-Palomeres JL 2005 LH improves early follicular recruitment in women over 38 years old. Reproductive BioMedicine Online 11, 409-414.
11. Grotjan HE, Esserman D, Beltsos AN, Uhler ML 2005 Statistical analysis of data from infertility patients: how to explicitly consider the decline in fertility associated with age. Fertility and Sterility 84 (Suppl. 1), S357-S358 [Abstr. P569].
12. Hugues J 2004 Comparative use of urinary and recombinant human chorionic gonadotropin in women. Treatments in Endocrinology 3, 371-379.
13. Lathi RB, Milki AA 2001 Recombinant gonadotropins. Current Womens Health Reports 1, 157-163.
14. Loumaye E, Martineau I, Piazzi A et al. 1996 Clinical assessment of human gonadotropins produced by recombinant DNA technology. Human Reproduction 11 (Suppl. 1), 95-107.
15. Ludwig M, Doody KJ, Doody KM 2003 Use of recombinant human chorionic gonadotropin in ovulation induction. Fertility and Sterility 79, 1051-1059.
16. Reichl H, Balen A, Jansen CAM 2002 Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins? Human Reproduction 17, 2501-2508.
17. The European Recombinant Human Chorionic Gonadotropin Study Group 2000 Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment-recombinant HCG versus urinary HCG. Human Reproduction 15, 1446-1451.
18. The International Recombinant Human Chorionic Gonadotropin Study Group 2001 Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. Fertility and Sterility 75, 1111-1118.
19. Trinchard-Lugan I, Khan A, Porchet HC, Munafo A 2002 Pharmakokinetics and pharmacodynamics of recombinant human chorionic gonadotropin in healthy male and female volunteers. Reproductive BioMedicine Online 4, 106-115.